Telcare developed the first FDA-cleared cellular enabled blood glucometer and cloud-based diabetes data repository system. This system transmits patient data into a cloud-based analytical engine, which monitors trends for caregivers to review.
“We chose the diabetes market as our first major digital population health initiative because of its significant overall burden on the healthcare system, with estimated direct annual costs in the U.S. of over $245 billion,” said Joseph H. Capper, president and CEO of BioTelemetry.
BioTelemetry acquired Telcare for upfront consideration of $7 million in cash. There is the potential for performance-based earn-outs of up to $5 million in cash.
More articles on health IT:
AHA endorses Teladoc
Philips to advance cancer treatment with New York Medical College collaboration
Henry Ford Hospital leverages 3-D imaging for improved cardiac outcomes
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
